Close Menu

optical sensor arrays

The Boston-based company is working to make its extracellular vesicle detection technology more widely available for research and biomarker discovery.

For nearly a quarter of a century, David Walt's laboratory at Tufts University has been applying micro- and nanotechnology to interrogate single molecules, analyze genetic variation, and investigate the contents and behavior of single cells. BioArray News spoke recently with Walt, co-founder and scientific advisory board chair of Illumina and Quanterix, about those activities.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.